THOMAS M NYLK

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease RENO, NV NPI 1700869708

General Payments — all program years on this page

$2,769.35

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 134
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $804.45 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $502.2315
Long term medical supply or device loan $302.221

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $372.0626
2019 $544.0839
2020 $165.596
2021 $302.0917
2022 $276.7315
2023 $304.3515
2024 $804.4516

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1076239038 AngioDynamics, Inc. $302.22 12/31/2024 Long term medical supply or device loan Undisputed 01/23/2026 View at CMS
1078101904 Janssen Pharmaceuticals, Inc $16.62 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1081701375 Lexicon Pharmaceuticals, Inc. $16.02 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1081701377 Lexicon Pharmaceuticals, Inc. $26.79 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087063668 Novartis Pharmaceuticals Corporation $21.04 04/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087063686 Novartis Pharmaceuticals Corporation $46.17 04/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092689999 Boston Scientific Corporation $13.18 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092690001 Boston Scientific Corporation $31.91 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101417785 E.R. Squibb & Sons, L.L.C. $17.86 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119445409 Medtronic, Inc. $14.85 08/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1129448946 Esperion Therapeutics, Inc. $27.46 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131536778 PFIZER INC. $18.04 02/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138897323 Edwards Lifesciences Corporation $47.83 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138897325 Edwards Lifesciences Corporation $30.60 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138897327 Edwards Lifesciences Corporation $151.52 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145808998 BIOTRONIK INC. $22.34 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.